Asst. Prof. Ahmet Can Timuçin who was born in İstanbul in 1983, completed his high school education in Robert College in 2003.
He received his undergraduate degree from Sabancı University Faculty of Engineering and Natural Sciences, Biological Sciences and Bioengineering Program in 2007. During his undergraduate education, he has contributed to the studies on novel drug candidates for multiple myeloma in State University of New York Downstate Medical Center.
He received his Master of Science degree from Columbia University Medical Center, Institute of Human Nutrition in 2008. During his masters, he has implemented valuable studies on hypoxia, PARP inhibitors and cell death related effects of Aldose Reductase.
In 2015, he completed his Ph.D. in Sabancı University Faculty of Engineering and Natural Sciences, Biological Sciences and Bioengineering Program. With this doctoral thesis, he has shown the presence of a novel protein-protein interaction system governing NFAT5 dependent Aldose Reductase (AR) protein expression.
In between 2015-2017, he has worked as a Post Doctoral Researcher in Sabancı University Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program. During post doctoral studies, he was involved in studies on SIRT6-NFAT5-AR axis, on Lipid Oxidation Products and on utilization of inhibitors of anti-apoptotic BCL-2 proteins in cancer.
Currently, he is continuing his studies in Üsküdar University Faculty of Engineering and Natural Sciences Chemical and Biological Engineering Program.
Academic interest of Dr. Timucin are: Cellular Signaling Mechanisms in Cancer, Transcription Factors, as well as, Computational and Experimental analysis of Protein-Peptide Interactions.